Since cancer cells display highly active nucleotide biosynthesis for proliferation and in response to methotrexate, a widely used cancer chemotherapy that inhibits the essential folate cycle enzyme dihydrofolate reductase (DHFR), modulating methionine metabolism could be a potential anticancer strategy. This evidence concerns the gene DHFR and cancer.